Accumetrics Achieves Iso 13485 Medical Device Certification

< BACK TO INTERNATIONAL starstarstarstarstar   Culture - International Press Release
8th January 2010, 06:46am - Views: 793

Culture International Accumetrics, Inc. 1 image

Culture International Accumetrics, Inc. 2 image


Accumetrics Achieves ISO 13485 Medical Device Certification

SAN DIEGO, Jan. 8 /PRNewswire-AsiaNet/ --

    Accumetrics, Inc., developer and marketer of the VerifyNow(R) System, the

first rapid and easy-to-use diagnostic system for measuring an individual's

response to multiple antiplatelet agents, announced today that the Company

has received a certificate of registration to ISO 13485: 2003, the Quality

Management System, a standard developed by the International Organization for

Standardization for medical device manufacturers.

    "We are extremely pleased to achieve certification to the ISO 13485:2003

standard, demonstrating our commitment to quality," said Timothy I. Still,

President and CEO of Accumetrics. "With achievement of this important

milestone, we can aggressively pursue our ambitious growth strategies and

international expansion plans for 2010."

    Accumetrics is committed to advancing medical understanding of platelet

function and enhancing quality of care for patients receiving antiplatelet

therapies by providing industry-leading and widely accessible diagnostic

tests for rapid platelet function assessment.

    Accumetrics' VerifyNow System is the first rapid and easy to use platform

for measuring an individual's response to multiple antiplatelet agents.

Addressing every major antiplatelet drug, including FDA-cleared products for

aspirin, P2Y12 inhibitors (e.g. prasugrel (Effient(R)) and clopidogrel

(Plavix(R))), and the GP IIb/IIIa inhibitors (e.g. ReoPro(R) and

Integrilin(R)), the VerifyNow System provides a valuable tool to help

physicians make more informed treatment decisions.

    The Accumetrics logo and VerifyNow are registered trademarks of

Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc.

Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is

a registered trademark of Sanofi-Aventis. Effient is a registered trademark

of Eli Lilly and Company.


    Megan Rusnack

    Lippert/Heilshorn & Associates


    Timothy I. Still

    President and CEO



SOURCE: Accumetrics, Inc.

    CONTACT: Megan Rusnack of Lippert/Heilshorn & Associates, 

Culture International Accumetrics, Inc. 3 image


   ; or 

             Timothy I. Still, President and CEO of Accumetrics, 




   Indonesian (

To view this and other AsiaNet releases please visit

news articles logo NEWS ARTICLES
Contact News Articles |Remove this article